These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7569344)

  • 1. Reticular pseudodrusen. A risk factor in age-related maculopathy.
    Arnold JJ; Sarks SH; Killingsworth MC; Sarks JP
    Retina; 1995; 15(3):183-91. PubMed ID: 7569344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.
    Cohen SY; Dubois L; Tadayoni R; Delahaye-Mazza C; Debibie C; Quentel G
    Br J Ophthalmol; 2007 Mar; 91(3):354-9. PubMed ID: 16973663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choroidal changes associated with reticular pseudodrusen.
    Querques G; Querques L; Forte R; Massamba N; Coscas F; Souied EH
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1258-63. PubMed ID: 22222508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine-green angiography in patients with occult choroidal neovascularization.
    Wolf S; Knabben H; Krombach G; Schaaf A; Solbach U; Reim M
    Ger J Ophthalmol; 1996 Sep; 5(5):251-6. PubMed ID: 8911945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration].
    Coscas F; Stanescu D; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Jun; 26(6):602-8. PubMed ID: 12910200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography.
    Ueda-Arakawa N; Ooto S; Ellabban AA; Takahashi A; Oishi A; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2014 May; 157(5):994-1004. PubMed ID: 24491418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICGA-guided laser photocoagulation of feeder vessels of choroidal neovascular membranes in age-related macular degeneration. Indocyanine green angiography.
    Desatnik H; Treister G; Alhalel A; Krupsky S; Moisseiev J
    Retina; 2000; 20(2):143-50. PubMed ID: 10783946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green angiography for recurrent choroidal neovascularization in age-related macular degeneration.
    Reichel E; Pollock DA; Duker JS; Puliafito CA
    Ophthalmic Surg Lasers; 1995; 26(6):513-8. PubMed ID: 8746571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
    Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Shiraga F; Ojima Y; Matsuo T; Takasu I; Matsuo N
    Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of reticular pseudodrusen.
    Sarks J; Arnold J; Ho IV; Sarks S; Killingsworth M
    Br J Ophthalmol; 2011 Jul; 95(7):979-85. PubMed ID: 21109695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.
    Friberg TR; Musch DC; Lim JI; Morse L; Freeman W; Sinclair S;
    Ophthalmology; 2006 Apr; 113(4):622.e1. PubMed ID: 16581422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degeneration.
    Böker T; Fang T; Steinmetz R
    Ger J Ophthalmol; 1993 Feb; 2(1):10-3. PubMed ID: 7679594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual results after submacular surgery for neovascularization in age-related macular degeneration.
    Roth DB; Downie AA; Charles ST
    Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized reticular pseudodrusen and their topographic relation to choroidal watershed zones and changes in choroidal volumes.
    Alten F; Clemens CR; Heiduschka P; Eter N
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3250-7. PubMed ID: 23599330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticular pseudodrusen are subretinal drusenoid deposits.
    Zweifel SA; Spaide RF; Curcio CA; Malek G; Imamura Y
    Ophthalmology; 2010 Feb; 117(2):303-12.e1. PubMed ID: 19815280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic polypoidal choroidal vasculopathy of the macula.
    Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
    Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration.
    Sandberg MA; Weiner A; Miller S; Gaudio AR
    Ophthalmology; 1998 Mar; 105(3):441-7. PubMed ID: 9499774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.